Tilray CEO: Opportunities in medical cannabis are tremendous

Tilray's stock is up today, but still down 80 percent from a February high. CNBC's Frank Holland reports on his conversation with Tilray CEO Irwin Simon about the company's quarterly earnings and what's next for the business.